Blogs

Contemplating the Dr Reddy’s Model

Is Synthetic Heparin the Solution?

What Does Lilly and Covance R&D Deal Mean for Industry?

Research and The Internet: Is the Tail Getting Too Short?

NIPTE’s Basu Operates in “Crisis” Mode

A Cafe Pharma for the R&D Set?

Angell Criticizes Big Pharma’s NIH (Not Invented Here) Syndrome

Microsoft Discusses SharePoint and Clinical Trials at DIA

Managing Change: What Keeps Pharma CEO’s Awake at Night